4-Formylphenylboronic Acid Bulk Price 2026: Industrial Trends & Sourcing Strategy
- Global bulk prices for 4-Formylphenylboronic acid are projected to stabilize in 2026 due to optimized synthesis routes and expanded manufacturing capacity.
- Industrial purity (≥97%) and consistent COA documentation are now baseline requirements for pharmaceutical intermediates in GMP-aligned supply chains.
- Strategic sourcing from integrated manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. offers cost efficiency, scalability, and technical support for API development.
As the pharmaceutical and agrochemical sectors intensify R&D into Suzuki-Miyaura cross-coupling reactions, demand for high-purity 4-Formylphenylboronic acid continues to rise. With CAS number 87199-17-5, this bifunctional building block—featuring both an aldehyde and a boronic acid group—enables precise molecular construction in oncology, CNS, and antiviral drug candidates. For procurement teams planning 2026 budgets, understanding the drivers behind bulk pricing is essential to secure cost-effective, reliable supply.
Current Bulk Pricing Trends for 4-Formylphenylboronic Acid
Historically, small-scale lab purchases of (4-formylphenyl)boronic acid have commanded premiums exceeding $100–150 per gram. However, industrial-scale buyers now benefit from economies of scale as global manufacturers refine their synthesis route and vertical integration. In 2026, bulk quotations for multi-kilogram orders (≥10 kg) with ≥97% industrial purity are expected to range between $850–$1,200 per kg, depending on volume tier, delivery timeline, and regulatory documentation.
This price compression stems from improved catalytic efficiency in lithiation-borylation sequences and reduced solvent waste in downstream purification. Leading producers have also invested in continuous-flow reactors to enhance yield consistency—critical for maintaining batch-to-batch reproducibility required in late-stage API synthesis.
Factors Influencing Industrial-Scale Pricing in 2026
Several interlinked variables shape the 2026 bulk price landscape for 4-Formylphenylboronic acid:
- Raw Material Volatility: Fluctuations in benzaldehyde and diboron ester feedstocks directly impact production costs. Integrated manufacturers mitigate this through long-term supplier contracts.
- Purity & Certification: Pharmaceutical applications demand rigorous COA (Certificate of Analysis) with full impurity profiling (HPLC, NMR, ICP-MS). Batches below 97% purity face steep discounts or rejection.
- Geopolitical Logistics: Export controls, shipping container availability, and customs clearance times affect landed costs—especially for time-sensitive projects.
- Scale of Order: Tiered pricing structures reward larger commitments. Orders above 50 kg often unlock negotiated rates and priority production slots.
Notably, the shift toward green chemistry has pressured suppliers to eliminate halogenated solvents from the manufacturing process, adding short-term CAPEX but improving long-term ESG compliance and reducing environmental liability.
How to Source Cost-Effective High-Purity Batches for API Synthesis
When sourcing high-purity 4-Formylphenylboronic Acid, buyers should prioritize suppliers with in-house analytical capabilities, GMP-aligned quality systems, and proven experience in pharmaceutical intermediates. A robust COA must include assay (≥97%), residual metals (<10 ppm), water content (KF ≤0.5%), and identity confirmation via 1H/11B NMR.
NINGBO INNO PHARMCHEM CO.,LTD., a premier global manufacturer of boronic acid derivatives, offers end-to-end control over the synthesis route—from raw material selection to crystallization and packaging. Their facility produces multi-ton annual capacity of 4-Formylphenylboronic acid under ISO 9001 and ISO 14001 standards, ensuring consistent industrial purity and rapid scale-up from grams to metric tons.
The company’s technical team supports clients with custom specifications, including anhydrous grades, solvent-free powders, or pre-dissolved solutions in THF or DMSO—tailored to specific coupling reaction conditions.
Comparative Bulk Pricing & Specifications (2026 Projection)
| Order Volume | Purity | Typical Price Range (USD/kg) | Lead Time | COA & Regulatory Support |
|---|---|---|---|---|
| 1–5 kg | ≥95% | $1,400 – $1,800 | 2–4 weeks | Basic (HPLC, mp) |
| 10–25 kg | ≥97% | $950 – $1,200 | 3–5 weeks | Full (NMR, ICP, KF, HPLC) |
| 50+ kg | ≥97% (Pharma Grade) | $850 – $1,050 | Negotiable (dedicated batch) | GMP-ready, DMF available |
For API developers, partnering with a technically adept global manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. reduces supply chain risk while ensuring access to material that meets stringent pharmacopeial expectations. Their focus on yield optimization in the manufacturing process translates into stable bulk pricing and minimized batch failure rates—key metrics for cost-conscious CMC teams.
In summary, the 2026 market for 4-Formylphenylboronic acid favors strategic partnerships over transactional purchasing. By aligning with a manufacturer that masters both chemistry and compliance, pharmaceutical innovators can secure high-performance intermediates at predictable costs—accelerating timelines from discovery to commercialization.